Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 SMALL DOSES OF PREDNISOLONE IN THE MANAGEMENT OF RHEUMATOID ARTHRITIS.

Literature DB >> 14130037

SMALL DOSES OF PREDNISOLONE IN THE MANAGEMENT OF RHEUMATOID ARTHRITIS.

Abstract

Entities: Chemical Disease

Keywords: ABSCESS; ADRENAL GLAND HYPOFUNCTION; ADRENAL GLANDS; ARTERITIS; ARTHRITIS, RHEUMATOID; INTESTINAL DISEASES; MUSCULAR DISEASES; PHARMACOLOGY; PITUITARY GLAND; PREDNISOLONE; PURPURA; SEPTICEMIA; TOXICOLOGIC REPORT

Mesh：

Substances：
Prednisolone

Year: 1964 PMID： 14130037 PMCID： PMC1010361 DOI： 10.1136/ard.23.2.158

Source DB: PubMed Journal: Ann Rheum Dis ISSN： 0003-4967 Impact factor: 19.103

× No keyword cloud information.

5 in total

1. DIAGNOSTIC criteria for rheumatoid arthritis: 1958 revision by a committee of the American Rheumatism Association.

Authors:
Journal: Ann Rheum Dis Date: 1959-03 Impact factor: 19.103

2. Some observations on diurnal variation of grip.

Authors: V WRIGHT
Journal: Clin Sci Date: 1959-02 Impact factor: 6.124

3. Clinical application of a new test of pituitary reserve.

Authors: G W LIDDLE; H L ESTEP; J W KENDALL; W C WILLIAMS; A W TOWNES
Journal: J Clin Endocrinol Metab Date: 1959-08 Impact factor: 5.958

4. Assessment of adrenocortical activity by assay of 17-ketogenic steroids in urine.

Authors: J K NORYMBERSKI; R D STUBBS; H F WEST
Journal: Lancet Date: 1953-06-27 Impact factor: 79.321

5. Plasma 17-hydroxycorticosteroids in patients with certain rheumatic diseases and in normal persons; preliminary report.

Authors: L E WARD; C WU; P S HENCH; H L MASON; C H SLOCUMB; H F POLLEY; J G MAYNE
Journal: Proc Staff Meet Mayo Clin Date: 1958-11-26

5 in total

15 in total

Review 1. [Glucocorticoids].

Authors: E Gromnica-Ihle
Journal: Z Rheumatol Date: 2016-08 Impact factor: 1.372

2. Plasma "cortisol" response to Synacthen in patients on long-term small-dose prednisone therapy.

Authors: J A Hicklin; M R Wills
Journal: Ann Rheum Dis Date: 1968-01 Impact factor: 19.103

3. Corticosteroid-induced hypothalamo-pituitary-adrenal axis suppression. Prospective study using two regimens of corticosteroid therapy.

Authors: K M Jasani; J A Boyle; W C Dick; J Williamson; A K Taylor; W W Buchanan
Journal: Ann Rheum Dis Date: 1968-07 Impact factor: 19.103

4. Effect of daily low dose prednisone, divided or single daily dose, in the treatment of African Americans with early rheumatoid arthritis.

Authors: Shuling Li; Doyt L Conn; Athan Tiliakos; Gaobin Bao; Kirk A Easley
Journal: Clin Rheumatol Date: 2018-01-03 Impact factor: 2.980

10. Efficacy of prednisone 1-4 mg/day in patients with rheumatoid arthritis: a randomised, double-blind, placebo controlled withdrawal clinical trial.

Authors: T Pincus; C J Swearingen; G Luta; T Sokka
Journal: Ann Rheum Dis Date: 2008-12-15 Impact factor: 19.103

SMALL DOSES OF PREDNISOLONE IN THE MANAGEMENT OF RHEUMATOID ARTHRITIS.

1. DIAGNOSTIC criteria for rheumatoid arthritis: 1958 revision by a committee of the American Rheumatism Association.

2. Some observations on diurnal variation of grip.

3. Clinical application of a new test of pituitary reserve.

4. Assessment of adrenocortical activity by assay of 17-ketogenic steroids in urine.

5. Plasma 17-hydroxycorticosteroids in patients with certain rheumatic diseases and in normal persons; preliminary report.

Review 1. [Glucocorticoids].

2. Plasma "cortisol" response to Synacthen in patients on long-term small-dose prednisone therapy.

3. Corticosteroid-induced hypothalamo-pituitary-adrenal axis suppression. Prospective study using two regimens of corticosteroid therapy.

4. Effect of daily low dose prednisone, divided or single daily dose, in the treatment of African Americans with early rheumatoid arthritis.

Review 5. Managing early presentation of rheumatoid arthritis. Systematic overview.

6. Time of day of prednisolone administration in rheumatoid arthritis.

7. Efficacy, safety and mechanism of action of modified-release prednisone in rheumatoid arthritis.

8. The timing of prednisolone dosage and its effect on morning stiffness in rheumatoid arthritis.

9. Bedtime single-dose prednisolone in clinically stable rheumatoid arthritis patients.

10. Efficacy of prednisone 1-4 mg/day in patients with rheumatoid arthritis: a randomised, double-blind, placebo controlled withdrawal clinical trial.